Search results
Dexcom vs. FreeStyle Libre: What to Know About These CGMs
Verywell Health via Yahoo News· 1 month agoDexcom and FreeStyle Libre are continuous glucose monitors that track blood sugar readings in real...
Abbott (ABT) Receives FDA Nod for FreeStyle Libre 3 System
Zacks via Yahoo Finance· 2 years agoAbbott Laboratories’ ABT next-generation FreeStyle Libre 3 system was recently approved by the FDA...
Insulet wins CE mark for integration of insulin pump with Abbott CGM
MedTech Dive via Yahoo Finance· 3 months agoDive Brief: Insulet has received a CE mark for the integration of its Omnipod 5 insulin pump and...
Abbott CEO talks diabetes market, device pricing at J.P. Morgan conference
MedTech Dive via Yahoo Finance· 4 months agoAbbott CEO Robert Ford expects the company to meet its goal of $10 billion in sales for its Libre...
Why your pet might need a glucose monitor
Popular Science via Yahoo News· 8 months agoAbout 1 in 300 dogs and cats are diagnosed with diabetes. The small medical sensors known as continuous glucose monitors, or CGMs, were first developed...
Dexcom Pummeled On A New FDA Clearance For Key Rival Abbott Laboratories
Investor's Business Daily· 1 year agoDexcom stock toppled Monday after the Food and Drug Administration cleared Abbott Laboratories to...
I tried Abbott’s new CGM Lingo for two weeks, and here’s what I learned
TechRadar via Yahoo News· 4 weeks agoLingo. I hit the plunger on the applicator device, and felt the needle slide into the meat of my...
Dexcom’s over-the-counter nod sets stage for broader CGM use
MedTech Dive via Yahoo Finance· 2 months agoThe Food and Drug Administration cleared the first over-the-counter continuous glucose monitor (CGM)...
Why Abbott Says It Won't Be A Casualty Of The Weight-Loss Battle
Investor's Business Daily· 7 months agoAbbott stock reversed a 10-day dive Thursday after showing patients taking popular diabetes and...
This Groundbreaking Device Just Keeps Winning for Abbott Labs
Motley Fool· 2 years agoIn late September, Abbott Laboratories (NYSE: ABT) shared encouraging results from a study that...